It means a non-randomised trial.
The optimal way is to have 2 (or more) study arms with patients evenly randomised. One receiving the drug, the other placebo.
Then you can compare the results between the groups.
the 001 trial did not do this as (in Kurtzbergs words), they were unwilling to subject children to placebo (i.e. no treatment)
- Forums
- ASX - By Stock
- MSB
- Ryoncil: ODAC/FDA Meeting Discussion
Ryoncil: ODAC/FDA Meeting Discussion, page-1062
-
-
- There are more pages in this discussion • 985 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.18 |
Change
0.013(1.07%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
$1.15 | $1.18 | $1.15 | $787.4K | 677.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 27029 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 42895 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 29780 | 1.175 |
22 | 73870 | 1.170 |
14 | 76832 | 1.165 |
12 | 68037 | 1.160 |
10 | 75453 | 1.155 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 65488 | 8 |
1.185 | 73730 | 9 |
1.190 | 88282 | 14 |
1.195 | 40105 | 5 |
1.200 | 83724 | 12 |
Last trade - 10.38am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online